Finchemo AG is an holding company operating in the pharmaceutical, hospital, and health-related projects sectors, aimed and investing to improve quality of life.
Finchemo was established with a mature foundation, thanks to a board with multi-generational experience in its fields of activity and a portfolio of participating companies already distinguished by international achievements and notable success.
Finchemo’s mission is to ensure business continuity for all group companies and to foster the exchange of skills through a common and interchangeable management approach. With this sustainability policy, Finchemo applies an even more innovative model than the frameworks that have always set its subsidiaries apart in their respective industries.
Therefore, a sound economic policy and sustainable growth strategy, used as a regulator of an aggressive and innovative commercial policy aimed at continuous expansion, make Finchemo and its subsidiaries a highly reliable and high-performing partner for your ventures.
Finchemo AG is acronym of “finance chemical and Biolife” and It is a new modern, lean holding company concept, comprising few, efficient players who combine high technical competence, entrepreneurial ethic, and proven loyalty to the project’s guiding values:
Finchemo was born as coordinating companies of different historical businesses active in the pharma, trading and healthcare sector.
Thanks to its structure and capacities, it is also a careful and enthusiastic investor in innovative start-up field.